Skip to main content
Erschienen in: NeuroMolecular Medicine 2/2009

01.06.2009 | Original Paper

A Homozygous Genetic Variant of Mitochondrial Uncoupling Protein 4 Exerts Protection Against the Occurrence of Multiple Sclerosis

verfasst von: Zoltan Szolnoki, Andras Kondacs, Yvette Mandi, Anita Bodor, Ferenc Somogyvari

Erschienen in: NeuroMolecular Medicine | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Multiple sclerosis (MS), which results in damage of the white matter at multiple foci, poses a far-reaching public health problem in view of the burden it imposes on the affected young and middle-aged. Some previous data suggested that roles could be played in the demyelinization of the white matter of the brain by the malfunctioning of the mitochondria and mitochondria-associated reactive oxygen species. In this context, we hypothesized that the finely tuned dynamic stability of the mitochondrial membrane potential (MMP), which is the main mirror of the functional state of the mitochondria, is essential for the intact nature of the glia cells in the brain. Setting out from this, our aim in this study was to examine how the rs10807344 and rs2270450 genetic variants of mitochondrial uncoupling protein 4 (mUCP4) can give rise to the development of MS, since mUCP4 is presumed to be of great importance in the regulation of the MMP and cellular energy metabolism. The clinical and genetic data on 120 relapsing-remitting MS patients and 250 neuroimaging alteration-free subjects were analyzed. The rs10807344 CC genotype proved to exert a protective effect against the occurrence of MS (neuroimaging alteration-free controls, 58%; MS group, 33%; P < 0.0000089; OR, 0.32; 95% CI: 0.2–0.56, P < 0.005). The present findings indirectly raise the possibility that a shift or imbalance in the finally regulated MMP plays a role in the development of MS.
Literatur
Zurück zum Zitat Bencsik, K., Rajda, C., Fuvesi, J., Klivenyi, P., Jardanhazy, T., Torok, M., et al. (2001). The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrad County, Hungary. European Neurology, 46, 206–209.PubMedCrossRef Bencsik, K., Rajda, C., Fuvesi, J., Klivenyi, P., Jardanhazy, T., Torok, M., et al. (2001). The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrad County, Hungary. European Neurology, 46, 206–209.PubMedCrossRef
Zurück zum Zitat Karg, E., Klivenyi, P., Bencsik, K., Turi, S., & Vecsei, L. (2003). Alpha-tocopherol and NADPH in the erythrocytes and plasma of multiple sclerosis patients. Effect of interferon-beta-1b treatment. European Neurology, 50, 215–219.PubMedCrossRef Karg, E., Klivenyi, P., Bencsik, K., Turi, S., & Vecsei, L. (2003). Alpha-tocopherol and NADPH in the erythrocytes and plasma of multiple sclerosis patients. Effect of interferon-beta-1b treatment. European Neurology, 50, 215–219.PubMedCrossRef
Zurück zum Zitat Komoly, S., Hudson, L. D., Webster, H. D., & Bondy, C. A. (1992). Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proceedings of the National Academy of Sciences of the United States of America, 89, 1894–1898.PubMedCrossRef Komoly, S., Hudson, L. D., Webster, H. D., & Bondy, C. A. (1992). Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proceedings of the National Academy of Sciences of the United States of America, 89, 1894–1898.PubMedCrossRef
Zurück zum Zitat Kurtzke, J. F. (1993). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDDS). Neurology, 33, 1442–1452. Kurtzke, J. F. (1993). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDDS). Neurology, 33, 1442–1452.
Zurück zum Zitat Liu, D., Chan, S. L., de Souza-Pinto, N. C., Slevin, J. R., Wersto, R. P., Zhan, M., et al. (2006). Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress. Neuromolecular Medicine, 8, 389–414.PubMedCrossRef Liu, D., Chan, S. L., de Souza-Pinto, N. C., Slevin, J. R., Wersto, R. P., Zhan, M., et al. (2006). Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress. Neuromolecular Medicine, 8, 389–414.PubMedCrossRef
Zurück zum Zitat Mattson, M. P., & Liu, D. (2003). Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death. Biochemical and Biophysical Research Communications, 9, 539–549.CrossRef Mattson, M. P., & Liu, D. (2003). Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death. Biochemical and Biophysical Research Communications, 9, 539–549.CrossRef
Zurück zum Zitat McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Annals of Neurology, 50, 121–127.PubMedCrossRef McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Annals of Neurology, 50, 121–127.PubMedCrossRef
Zurück zum Zitat Miller, D. H., Barkof, F., Berry, I., Kappos, L., Scotti, S., & Thompson, A. J. (1991). Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: Concerted action guidelines. Journal of Neurology, Neurosurgery and Psychiatry, 54, 683–688.CrossRef Miller, D. H., Barkof, F., Berry, I., Kappos, L., Scotti, S., & Thompson, A. J. (1991). Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: Concerted action guidelines. Journal of Neurology, Neurosurgery and Psychiatry, 54, 683–688.CrossRef
Zurück zum Zitat Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215–1218.PubMedCrossRef Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215–1218.PubMedCrossRef
Zurück zum Zitat Otaegui, D., Saenz, A., Ruiz-Martinez, J., Olaskoaga, J., & López de Munain, A. (2007). UCP2 and mitochondrial haplogroups as a multiple sclerosis risk factor. Multiple Sclerosis, 13(4), 454–458.PubMed Otaegui, D., Saenz, A., Ruiz-Martinez, J., Olaskoaga, J., & López de Munain, A. (2007). UCP2 and mitochondrial haplogroups as a multiple sclerosis risk factor. Multiple Sclerosis, 13(4), 454–458.PubMed
Zurück zum Zitat Poser, C. M., Paty, D. W., Scheimberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., et al. (1983). New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Annals of Neurology, 13, 227–231.PubMedCrossRef Poser, C. M., Paty, D. W., Scheimberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., et al. (1983). New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Annals of Neurology, 13, 227–231.PubMedCrossRef
Zurück zum Zitat Szolnoki, Z. (2007). Pathomechanism of leukoaraiosis: Molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis). Neuromolecular Medicine, 9, 21–33.PubMedCrossRef Szolnoki, Z. (2007). Pathomechanism of leukoaraiosis: Molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis). Neuromolecular Medicine, 9, 21–33.PubMedCrossRef
Zurück zum Zitat Szolnoki, Z., Kondacs, A., Mandi, Y., & Somogyvari, F. (2007a). A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: Gene-environmental interactions behind vascular white matter demyelinization. Journal of Molecular Neuroscience, 33, 173–179.PubMedCrossRef Szolnoki, Z., Kondacs, A., Mandi, Y., & Somogyvari, F. (2007a). A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: Gene-environmental interactions behind vascular white matter demyelinization. Journal of Molecular Neuroscience, 33, 173–179.PubMedCrossRef
Zurück zum Zitat Szolnoki, Z., Kondacs, A., Mandi, Y., & Somogyvari, F. (2007b). A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: The janus face of the kinesin light-chain 1 56836CC genetic variant. Neuromolecular Medicine, 9, 335–339.PubMedCrossRef Szolnoki, Z., Kondacs, A., Mandi, Y., & Somogyvari, F. (2007b). A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: The janus face of the kinesin light-chain 1 56836CC genetic variant. Neuromolecular Medicine, 9, 335–339.PubMedCrossRef
Zurück zum Zitat Thompson, A. J., Montalban, X., Barkhof, F., et al. (2000). Diagnostic criteria for primary progressive multiple sclerosis: A position paper. Annals of Neurology, 47, 831–835.PubMedCrossRef Thompson, A. J., Montalban, X., Barkhof, F., et al. (2000). Diagnostic criteria for primary progressive multiple sclerosis: A position paper. Annals of Neurology, 47, 831–835.PubMedCrossRef
Zurück zum Zitat Tintoré, M., Rovira, A., Martinez, M. J., et al. (2000). Isolated demyelinating syndromes: Comparison of different MR imaging criteria to predict conversion clinically definite multiple sclerosis. American Journal of Neuroradiology, 21, 702–706.PubMed Tintoré, M., Rovira, A., Martinez, M. J., et al. (2000). Isolated demyelinating syndromes: Comparison of different MR imaging criteria to predict conversion clinically definite multiple sclerosis. American Journal of Neuroradiology, 21, 702–706.PubMed
Zurück zum Zitat Vogler, S., Goedde, R., Miterski, B., Gold, R., Kroner, A., Koczan, D., et al. (2005). Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis. Journal of Molecular Medicine, 83(10), 806–811.PubMedCrossRef Vogler, S., Goedde, R., Miterski, B., Gold, R., Kroner, A., Koczan, D., et al. (2005). Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis. Journal of Molecular Medicine, 83(10), 806–811.PubMedCrossRef
Zurück zum Zitat Vogler, S., Pahnke, J., Rousset, S., Ricquier, D., Moch, H., Miroux, B., et al. (2006). Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis. American Journal of Pathology, 168(5), 1570–1575.PubMedCrossRef Vogler, S., Pahnke, J., Rousset, S., Ricquier, D., Moch, H., Miroux, B., et al. (2006). Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis. American Journal of Pathology, 168(5), 1570–1575.PubMedCrossRef
Zurück zum Zitat Yasuno, K., Ando, S., Misumi, S., Makino, S., Kulski, J. K., Muratake, T., et al. (2007). Synergistic association of mitochondrial uncoupling protein (UCP) genes with schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144B(2), 250–253.CrossRef Yasuno, K., Ando, S., Misumi, S., Makino, S., Kulski, J. K., Muratake, T., et al. (2007). Synergistic association of mitochondrial uncoupling protein (UCP) genes with schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144B(2), 250–253.CrossRef
Zurück zum Zitat Yoon, Y., Park, B. L., Cha, M. H., Kim, K. S., Cheong, H. S., Choi, Y. H., et al. (2007). Effects of genetic polymorphisms of UCP2 and UCP3 on very low calorie diet-induced body fat reduction in Korean female subjects. Biochemical and Biophysical Research Communications, 359(3), 451–456. Yoon, Y., Park, B. L., Cha, M. H., Kim, K. S., Cheong, H. S., Choi, Y. H., et al. (2007). Effects of genetic polymorphisms of UCP2 and UCP3 on very low calorie diet-induced body fat reduction in Korean female subjects. Biochemical and Biophysical Research Communications, 359(3), 451–456.
Zurück zum Zitat Yu, X., Wieczorek, S., Franke, A., Yin, H., Pierer, M., Sina, C., et al. (2009). Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases. doi:10.1038/gene.2009.29. Yu, X., Wieczorek, S., Franke, A., Yin, H., Pierer, M., Sina, C., et al. (2009). Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases. doi:10.​1038/​gene.​2009.​29.
Metadaten
Titel
A Homozygous Genetic Variant of Mitochondrial Uncoupling Protein 4 Exerts Protection Against the Occurrence of Multiple Sclerosis
verfasst von
Zoltan Szolnoki
Andras Kondacs
Yvette Mandi
Anita Bodor
Ferenc Somogyvari
Publikationsdatum
01.06.2009
Verlag
Humana Press Inc
Erschienen in
NeuroMolecular Medicine / Ausgabe 2/2009
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI
https://doi.org/10.1007/s12017-009-8071-4

Weitere Artikel der Ausgabe 2/2009

NeuroMolecular Medicine 2/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.